Matt Emmens presentation earlier this week at Cowens was more than interesting. If anyone thinks that Vyvanse isn't going to be a huge success then you better listen to him. He also slated Street.com for their incorrect analysis of XR v Vyvanse. Shire are clearly going to sell huge amounts of Vyvanse to adults in the US and he talks about the big opportunity in that area. They are going to advertise Vyvanse for adults for the first time. He also once again talked about the huge potential outside the US. If Shire gets NRPH its a sure fire winner to be a takeover target itself.